Efficacy and safety of anti-PD-1 antibody SHR-1210 combined with apatinib in first-line treatment for advanced lung squamous carcinoma: A phase II studyJ. Wang,Z. Zhang, F. Zhang, Q. Song, L. Zhang,Z. Liu,J. Ma,X. Yan,L. Wang, H. Tao,S. Zhang,X. Li, X. Zhi,Y. Hu,S. JiaoANNALS OF ONCOLOGY（2019）引用 0|浏览51暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
